Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
155 E 76 St
New York, NY 10021Phone+1 646-415-1710Fax+1 866-269-1680- Is this information wrong?
Education & Training
- Beth Israel Deaconess Medical CenterPost-Doctoral Fellowship, Howard Hughes Medical Institute Postdoctoral Fellowship, Hemostasis & Thrombosis, 1999 - 2005
- Orthopaedic Institute for ChildrenPost-Doctoral Fellowship, Hemophilia Center, 1997 - 1998
- University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1995 - 1997
- University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 1992 - 1995
- Stony Brook University Health Sciences Center School of MedicineClass of 1992
- Massachusetts Institute of TechnologySB & SB, Chemistry & Life Science
Certifications & Licensure
- NY State Medical License 1993 - 2026
- CA State Medical License 1993 - 2025
- MA State Medical License 1999 - 2024
- ME State Medical License 2022 - 2023
- WA State Medical License 2019 - 2022
- OR State Medical License 2019 - 2021
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
Publications & Presentations
PubMed
- 51 citationsRecombinant factor VIIa analog in the management of hemophilia with inhibitors: Results from a multicenter, randomized, controlled trial of vatreptacog alfaSteven R. Lentz, Silke Ehrenforth, F. Abdul Karim, Tadashi Matsushita, K. N. Weldingh, Jerzy Windyga, J. N. Mahlangu, A. Weltermann, E. de Paula, M. Cerqueira, Silva Z...> ;Journal of Thrombosis and Haemostasis. 2014 Aug 1
- 8 citationsPatient characteristics that influence efficacy of prophylaxis with rFVIII‐FS three times per week: a subgroup analysis of the LIPLONG studyShadan Lalezari, A. Coppola, J. C. Lin, Monika Maas Enriquez, D. Tseneklidou-Stoeter, Jerry S. Powell, Jørgen Ingerslev> ;Haemophilia. 2014 May 1
- 126 citationsPhase I study of BAY 94‐9027, a PEGylated B‐domain‐deleted recombinant factor VIII with an extended half‐life, in subjects with hemophilia AT. E. Coyle, Mark T. Reding, J. C. Lin, L. A. Michaels, A. Shah, Jerry S. Powell> ;Journal of Thrombosis and Haemostasis. 2014 Apr 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: